Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02663921
Other study ID # 14-02039
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2015
Est. completion date April 17, 2019

Study information

Verified date June 2019
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to learn more about the potential effects of visible light on the skin. More specifically, this study will examine whether an incandescent lamp (light bulb) or LED light bulb can cause skin to become darker. Investigators will determine the minimum threshold dose required to achieve immediate pigmentation darkening (IPD), persistent pigmentation darkening (PPD), and delayed tanning (DT) for Fitzpatrick skin types IV - VI utilizing two visible light sources.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date April 17, 2019
Est. primary completion date April 17, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Be a healthy volunteer with Fitzpatrick skin types I-VI;

- Agree to abide by the Investigator's guidelines regarding photosensitizing drugs and photoprotection;

- Be able to understand the requirements of the study, the risks involved, and be able to sign the informed consent form;

- Agree to follow and undergo all study-related procedures.

Exclusion Criteria:

- Women who are lactating, pregnant, or planning to become pregnant;

- Patients with a recent history of vitiligo, melasma, and other disorders of pigmentation with the exception of post-inflammatory hyperpigmentation;

- Patients with a known history of photosensitivity disorders;

- Photosensitizing medications may be continued throughout of the study at the discretion of the investigator ;

- Patients with a known history of melanoma or non-melanoma skin cancers;

- Concomitant use of tanning beds;

- Sun exposure of the irradiated or control areas;

- Patients with serious systemic disease.

- Patients with a known history of hypersensitivity to adhesives including adhesive tape.

Study Design


Intervention

Other:
Part A: Baseline-Week 2
The study doctor will shine 2 different light bulbs (one a regular or incandescent bulb and the other an LED light bulb) on 12 different areas of patients skin approximately 6 square centimeters in size (less than 1 square inch or the size of your thumb nail). Each light bulb will be exposed to your skin for approximately 20 - 35 minutes. After exposure, the study doctor will perform skin assessments at 3 time points: Immediately after the light exposure; 30 minutes after light exposure; and 1 hour after light exposure.
Part B: Week 4-Week 12
The study doctor will perform the same 4 skin assessments used in Part A at each visit to assess potential changes in your skin: Digital Photography Visual Clinical Assessment Spectroscopy Colorimetry

Locations

Country Name City State
United States New York University School of Medicine New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diffuse Reflectance Spectroscopy (DRS) to examine the optical properties of melanin and deoxyhemoglobin 12 weeks
Primary Quantification of the scattering and absorption properties of the skin in which the beam of light will penetrate using DRS 12 weeks
Primary Measurement of pigmentation changes induced by the two light sources using diffuse reflectance spectrometer 12 weeks
Primary Measurement of pigmentation changes induced by the two light sources using Colorimetry 12 weeks
Primary Measurement of pigmentation changes induced by the two light sources using Cross-Polarized Digital Photography 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT01012453 - A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema N/A
Not yet recruiting NCT05561595 - Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma N/A
Completed NCT00910260 - Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels Phase 4
Completed NCT02309905 - Evaluation of Tele-expertise for Inmates With a Dermatological Lesion N/A
Completed NCT02338076 - A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin N/A
Completed NCT02465476 - Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine N/A
Completed NCT00001648 - Structure of the Herpes Simplex Virus Receptor N/A
Completed NCT01187732 - Washing Without Water: Cost-effectiveness of a Rapidly Spreading Nursing Intervention in Bedridden Patients' N/A